Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Gore Seeks Add-On Payment For TAG Endograft In Advance Of FDA Approval

This article was originally published in The Gray Sheet

  • News

Executive Summary

W. L. Gore is requesting new technology add-on payment from Medicare for its TAG thoracic aortic aneurysm (TAA) endograft based on data showing it to be significantly safer than surgical repair

You may also be interested in...



Reimbursement Experts Say Trial Endpoints Must Fit Add-On Payment Criteria

Device firms intending to seek a new technology add-on payment for their technology should craft their pivotal clinical trial endpoints to meet CMS' substantial clinical improvement criteria, according to W.L. Gore associate Antoinette Sheen

Reimbursement Experts Say Trial Endpoints Must Fit Add-On Payment Criteria

Device firms intending to seek a new technology add-on payment for their technology should craft their pivotal clinical trial endpoints to meet CMS' substantial clinical improvement criteria, according to W.L. Gore associate Antoinette Sheen

AdvaMed Provides CMS With New Technology Add-On Payment Wish List

AdvaMed is urging CMS to make its annual "town hall" meeting on new technology add-on payment submissions more interactive

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Tags:
Latest Headlines

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application

See All
UsernamePublicRestriction

Register

MT021681

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By